Related Experiment Video
Updated: Apr 15, 2026

In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages
Published on: December 30, 2017
Impaired Macrophage Efferocytosis: Shared Mechanisms and Therapeutic Implications in Immune-Mediated Inflammatory
Zelin He1, Nuoshi Chen1, Yan Zhang1
1Department of Rheumatology and Immunology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510280, People's Republic of China.
Abstract:
Efferocytosis, the specialized phagocytic clearance of apoptotic cells, is a fundamental mechanism for maintaining tissue homeostasis and immune tolerance. Among professional phagocytes, macrophages play a central role due to their high plasticity and tissue-resident properties. By recognizing and engulfing apoptotic cells through a repertoire of receptors and bridging molecules, macrophages prevent secondary necrosis and inflammation and actively shape the local immune microenvironment via metabolic and epigenetic reprogramming. Defective efferocytosis has been increasingly implicated in the pathogenesis of immune-mediated inflammatory diseases (IMIDs), including systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, inflammatory bowel disease, psoriasis, atopic dermatitis, and autoimmune liver diseases. Impairments in efferocytosis trigger persistent inflammation, autoantigen exposure, and tissue damage, thereby fueling chronic disease progression. Recent mechanistic studies highlight the dysregulation of TAM receptors, bridging molecules, and intracellular signaling pathways as critical determinants of efferocytosis dysfunction in IMIDs. In this review, we propose defective macrophage efferocytosis as a shared pathogenic mechanism across diverse IMIDs and integrate emerging evidence linking efferocytosis to immunometabolic and epigenetic rewiring in chronic inflammation. We further discuss therapeutic strategies targeting efferocytosis pathways and highlight key translational challenges and opportunities. By positioning efferocytosis as a central pathogenic node and a readily targetable mechanism across the spectrum of IMIDs, this review offers a conceptual framework that links fundamental mechanistic insights with clinical translation, thereby laying the groundwork for precision immunomodulatory strategies that aim to restore immune homeostasis rather than merely suppress inflammation.
Insights
Defective efferocytosis, the clearance of dead cells by macrophages, drives immune-mediated inflammatory diseases. Targeting this process offers a path to restoring immune balance and developing new therapies for chronic conditions.
Area of Science:
- Immunology
- Cell Biology
- Pathogenesis
Background:
- Efferocytosis is crucial for tissue homeostasis and immune tolerance, primarily mediated by macrophages.
- Macrophages engulf apoptotic cells via specific receptors, preventing inflammation and reprogramming the immune microenvironment.
- Defective efferocytosis is linked to numerous immune-mediated inflammatory diseases (IMIDs).
Purpose of the Study:
- To propose defective macrophage efferocytosis as a common pathogenic mechanism in IMIDs.
- To integrate evidence linking efferocytosis to immunometabolic and epigenetic changes in chronic inflammation.
- To discuss therapeutic strategies targeting efferocytosis for IMIDs.
Main Methods:
- Review of mechanistic studies on efferocytosis pathways in IMIDs.
- Analysis of the role of TAM receptors, bridging molecules, and signaling pathways.
- Integration of immunometabolic and epigenetic reprogramming concepts.
Main Results:
- Dysregulation of efferocytosis pathways, including TAM receptors, contributes to IMID pathogenesis.
- Impaired efferocytosis leads to persistent inflammation, autoantigen exposure, and tissue damage.
- Efferocytosis dysfunction is associated with immunometabolic and epigenetic alterations.
Conclusions:
- Defective macrophage efferocytosis is a shared pathogenic mechanism across diverse IMIDs.
- Targeting efferocytosis pathways presents a promising strategy for restoring immune homeostasis.
- This review provides a framework for developing precision immunomodulatory therapies for IMIDs.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

